A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473). (Q33347267)

26 July 2017

A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473). (English)

1 reference

26 July 2017

P Beale

1

1 reference

26 July 2017

I Judson

2

1 reference

26 July 2017

A O'Donnell

3

1 reference

26 July 2017

J Trigo

4

1 reference

26 July 2017

C Rees

5

1 reference

26 July 2017

F Raynaud

6

1 reference

26 July 2017

A Turner

7

1 reference

26 July 2017

L Simmons

8

1 reference

26 July 2017

L Etterley

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

British Journal of Cancer

26 July 2017

1 reference

26 July 2017

88

1 reference

26 July 2017

7

1 reference

26 July 2017

1128-1134

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600854

26 July 2017

0 references

cites work

New developments and approaches in the platinum arena

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376375

Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376375

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376375

A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376375

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376375

Prediction of creatinine clearance from serum creatinine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376375

Biotransformation of the platinum drug JM216 following oral administration to cancer patients.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600854

cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376375

Comparative pharmacokinetics of cisplatin and three analogues in mice and humans

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12671715

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12671715

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6600854

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference